Mapping the sevoflurane-binding sites of calmodulin

Pharmacology Research and Perspectives

Volumn 2, Issue 1, 2014, Pages 1-12

  Brath, Ulrika ^a   Lau, Kelvin ^b   Van Petegem, Filip ^b   Erdélyi, Máté ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ITC; NMR; Anesthesia; Anesthetic binding; Calmodulin; Sevoflurane

Indexed keywords

CALCIUM; CALMODULIN; SEVOFLURANE;

ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; DRUG BINDING; HETERONUCLEAR OVERHAUSER ENHANCEMENT SPECTROSCOPY; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY;

EID: 84966344154     PISSN: None     EISSN: 20521707     Source Type: Journal    
DOI: 10.1002/prp2.25     Document Type: Article

References (62)

1. Arhem P, Klement G, Nilsson J (2003). Mechanisms of anesthesia: towards integrating network, cellular, and molecular level modeling. Neuropsychopharm 28: S40-S47.
2. Aulabaugh A, Niemczura WP, Gibbons WA (1984). High-field proton NMR-studies of tryptic fragments of camodulin - a comparison with the native protein. Biochem Biophys Res Commun 118: 225-232.
3. Babu YS, Bugg CE, Cook WJ (1988). Structure of calmodulin refined at 2.2 Å resolution. J Mol Biol 204: 191-204.
4. 7Li. Magn Reson Chem 34: 532-537.
5. 13C assignment of Lys and Leu sidechains of staphylococcal nuclease using HCCH-COSY and HCCH-TOCSY 3D NMR spectroscopy. FEBS Lett 281: 33-38.
6. Bertaccini EJ, Trudell JR, Franks NP (2007). The common chemical motifs within anesthetic binding sites. Anesth Analg 104: 318-324.
7. Blanck G (1999a). HLA class II expression in human tumor lines. Microbes Infect 1: 913-918.
8. 2+ homeostasis. Ital J Neurol Sci 20: 431-435.
9. Brath U, Lau K, Van Petegem F, Erdelyi M (2013). The general anaesthetic binding site of calmodulin disrupts Ryanodine peptide binding. Biophys J 104: 445a.
10. Brini M, Fedrizzi L, Carafoli E. (2008). Calcium signaling. Pp. 1-10 in N. Civjan, ed. Wiley encyclopedia of chemical biology. John Wiley & Sons, Inc (Online service)
11. Cavanagh J, Fairbrother WJ, Palmer AG, III, Rance M, Skelton NJ (1996). P. 756 in Protein NMR spectroscopy: principles & practice. 2nd ed. Academic Press Inc., San Diego, CA.
12. Chin D, Means AR (2000). Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10: 322-328.
13. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995). NMRPipe - a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
14. Di Paolo T, Sándorfy C (1974). Fluorocarbon anaesthetics break hydrogen bonds. Nature 252: 471-472.
15. 19F-NMR study. Proc Natl Acad Sci USA 90: 6478-6482.
16. Ebert TJ, Schmid PG. (2009). Inhaled Amesthetics. 6 ed. Clinical Anesthesia, Lippincott Williams and Wilkins, Wolters Kluwer Health, Philadelphia, PA.
17. Eckenhoff RG, Johansson JS (1997). Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 49: 343-367.
18. Edelhoch H (1967). Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6: 1948-1954.
19. Fesik SW, Zuiderweg ERP (1988). Heteronuclear 3D NMR-spectroscopy - a strategy for the simplification of homonuclear 2D NMR spectra. J Magn Reson 78: 588-593.
20. Franks NP, Lieb WR (1978). Where do general anaesthetics act? Nature 274: 339-342.
21. Franks NP, Lieb WR (1984). Do general anaesthetics act by competitive binding to specific receptors? Nature 310: 599-601.
22. Franks NP, Lieb WR (1990). Mechanisms of general anesthesia. Environ Health Perspect 87: 199-205.
23. Franks NP, Lieb WR (1994). Molecular and cellular mechanisms of general anesthesia. Nature 367: 607-614.
24. Glass PS (1998). Anesthetic drug interactions: an insight into general anesthesia-its mechanism and dosing strategies. Anesthesiology 88: 5-6.
25. Horváth I, Harmat V, Perczel A, Pálfi V, Nyitray L, Nagy A, et al. (2005). The structure of the complex of calmodulin with KAR-2: a novel mode of binding explains the unique pharmacology of the drug. J Biol Chem 280: 8266-8274.
26. Jeener J, Meier BH, Bachmann P, Ernst RR (1979). Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 71: 4546-4553.
27. Kainosho M, Torizawa T, Iwashita Y, Terauchi T, Ono AM, Güntert P (2006). Optimal isotope labelling for NMR protein structure determinations. Nature 440: 52-57.
28. Kay LE, Ikura M, Tschudin R, Bax A (1990). Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins. J Magn Reson 213: 423-441.
29. Koradi R, Billeter M, Wüthrich K (1996). MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51-56.
30. 2+ in neurones and non-muscular cells. Br J Anaesth 71: 47-58.
31. Kumar A, Ernst RR, Wüthrich K (1980). A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun 95: 1-6.
32. Landers DF, Becker GL, Wong KC (1989). Calcium, calmodulin, and anesthesiology. Anesth Analg 69: 100-112.
33. 2+ binding properties of calmodulin. Anesthesiology 83: 120-126.
34. Maximciuc AA, Putkey JA, Shamoo Y, MacKenzie KR (2006). Complex of calmodulin with a ryanodine receptor target reveals a novel, flexible binding mode. Structure 14: 1547-1556.
35. Meador WE, Means AR, Quiocho FA (1993). Modulation of calmodulin plasticity in molecular recognition on the basis of X-ray structures. Science 262: 1718-1721.
36. Metrangolo P, Neukirch H, Pilati T, Resnati G (2005). Halogen bonding based recognition processes: a world parallel to hydrogen bonding. Acc Chem Res 38: 386-395.
37. Metrangolo P, Murray JS, Pilati T, Politzer P, Resnati G, Terraneo G (2011). Fluorine-centered halogen bonding: a factor in recognition phenomena and reactivity. Cryst Growth Des 11: 4238-4246.
38. Meyer HH (1899). Zur Theorie der Alkoholnarkose. Arch Exp Pathol Pharmacol 42: 109-118.
39. Michel F, Constantin JM (2009). Sevoflurane inside and outside the operating room. Expert Opin Pharmacother 10: 861-873.
40. Mody I, Tanelian DL, MacIver MB (1991). Halothane enhances tonic neuronal inhibition by elevating intracellular calcium. Brain Res 538: 319-323.
41. Nisius L, Stadler M, Kalbitzer HR, Brunner E (2005). NMR spectroscopic study of noble gas binding into the engineered cavity of HPr(I14A) from Staphylococcus carnosus. J Phys Chem B 109: 17795-17798.
42. 2+ and decrease target affinity for calmodulin. Biochim Biophys Acta 1691: 161-167.
43. Orser BA (2007). Lifting the fog around anesthesia. Sci Am 296: 54-61.
44. Osawa M, Swindells MB, Tanikawa J, Tanaka T, Mase T, Furuya T, et al. (1998). Solution structure of calmodulin-W-7 complex: The basis of diversity in molecular recognition. J Mol Biol 276: 165-176.
45. Östergren G (1944). Colchicine mitosis, chromosome contraction, narcosis and protein chain folding. Hereditas 30: 429-467.
46. Rasmussen H (1986). The calcium messenger system (1-2). N Engl J Med 314: 1094-1101 and 1718-1721.
47. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P (2006). Mutations in RyR1 in malignant hyperthermia and central core disease. Hum Mutat 27: 977-989.
48. Saimi Y, Kung C (2002). Calmodulin as an ion channel subunit. Annu Rev Physiol 64: 289-311.
49. Sandorfy C (2004). Hydrogen bonding and anaesthesia. J Mol Struct 708: 3-5.
50. Sarhan MF, Tung CC, Van Petegem F, Ahern CA (2012). Crystallographic basis for calcium regulation of sodium channels. Proc Nat Acad Sci USA 109: 3558-3563.
51. Siivari K, Zhang M, Palmer AG, Vogel HJ (1995). NMR studies of the methionine methyl groups in calmodulin. FEBS Lett 366: 104-108.
52. Streiff JH, Juranic NO, Macura SI, Warner DO, Jones KA, Perkins WJ (2004). Saturation transfer difference nuclear magnetic resonance spectroscopy as a method for screening proteins for anesthetic binding. Mol Pharmacol 66: 929-935. Note: Unpublished structures of halothane in complex with the CaM N- and C-terminal domains were deposited in PDB with codes 2KUG and 2KUH.
53. Streiff JH, Allen TW, Atanasova E, Juranic N, Macura S, Penheiter AR, et al. (2006). Prediction of volatile anesthetic binding sites in proteins. Biophys J 91: 3405-3414.
54. Tanaka T, Hidaka H (1980). Hydrophobic regions function in calmodulin-enzyme(s) interactions. J Biol Chem 255: 1078-1080.
55. Tang P, Zubryzcki I, Xu Y (2001). Ab initio calculation of structures and properties of halogenated general anesthetics: halothane and sevoflurane. J Comput Chem 22: 436-444.
56. 15N-NMR relaxation measurements. Eur J Biochem 230: 1014-1024.
57. Trogdon G, Murray JS, Concha MC, Politzer P (2007). Molecular surface electrostatic potentials and anesthetic activity. J Mol Model 13: 313-318.
58. 2+-calmodulin. Nat Struct Biol 1: 795-801.
59. Villars PS, Kanusky JT, Dougherty TB (2004). Stunning the neural nexus: mechanisms of general anesthesia. AANA J 72: 197-205.
60. 2H labeled proteins with high-sensitivity. J Am Chem Soc 116: 11655-11666.
61. Yamniuk AP, Vogel HJ (2004). Calmodulin's flexibility allows for promiscuity in its interactions with target proteins and peptides. Mol Biotechnol 27: 33-57.
62. Zhang T, Johansson JS (2003). An isothermal titration calorimetry study on the binding of four volatile general anesthetics to the hydrophobic core of a four-alpha-helix bundle protein. Biophys J 85: 3279-3285.